A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

NCT01203072 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

523

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism
Deep Vein Thrombosis
Total Knee Arthroplasty

Interventions

DRUG: DU-176b
DRUG: DU-176b
DRUG: DU-176b
DRUG: DU-176b
DRUG: Placebo

Sponsor

Daiichi Sankyo Co., Ltd.